---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-105441"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2025-08-08T23:59:59+00:00"
generated_at: "2026-05-17T16:41:32.708821+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tempus AI Q2 rev $315M (+90% YoY); raises FY25 guidance to $1.26B, adj EBITDA $5M

## Summary
- Revenue $314.6M (+89.6% YoY); genomics up 115% to $241.8M; data/services +35.7% to $72.8M.
- Gross profit $195.0M (+158% YoY); net loss improved to ($42.8M) from ($552.2M); adj EBITDA ($5.6M) vs ($31.2M).
- Issued $750M 0.75% convertible notes; cash $293M; FY guidance raised: rev ~$1.26B, adj EBITDA $5M.
- Oncology testing volume +26% YoY; hereditary +32%; >212,000 NGS tests delivered in Q2.

## SEC filing metadata
- accession: 0000950170-25-105441
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2025-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000095017025105441/0000950170-25-105441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000095017025105441/tem-20250808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-105441
- JSON: https://secwatch.observer/filing/0000950170-25-105441.json
- Plain text: https://secwatch.observer/filing/0000950170-25-105441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.